HanAll Biopharma Appoints Almira Chabi as Chief Medical Officer and Chief Development Officer
SEOUL, South Korea, Feb. 21, 2022 /PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS) announced today the appointment of Almira Chabi, M.D. as Chief...
Stay updated with breaking news from Artificial Intelligence Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SEOUL, South Korea, Feb. 21, 2022 /PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS) announced today the appointment of Almira Chabi, M.D. as Chief...
/PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS) announced today the appointment of Almira Chabi, M.D. as Chief Medical Officer and Chief Development Officer...
/PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS) announced today the appointment of Almira Chabi, M.D. as Chief Medical Officer and Chief Development Officer...
HanAll Biopharma Appoints Almira Chabi as Chief Medical Officer and Chief Development Officer - read this article along with other careers information, tips and advice on BioSpace
We are in the midst of a moment where AI is under the microscope, with policymakers picking apart AI contributions and demanding that AI meet high standards of performance. However, I fear in the drive to make AI better, the perfect may become the enemy of the good.